Investigational α-synuclein aggregation inhibitors hope for Parkinson’s disease /

Introduction: The therapeutic management of Parkinson’s disease (PD) is challenging and has not been fully resolved. The main challenges include motor fluctuations and levodopa-induced dyskinesia. Moreover, no disease-modifying or neuroprotective therapy is currently available. Areas covered: This r...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Török Nóra
Majláth Zsófia
Szalárdy Levente
Vécsei László
Dokumentumtípus: Cikk
Megjelent: 2016
Sorozat:EXPERT OPINION ON INVESTIGATIONAL DRUGS 25 No. 11
doi:10.1080/13543784.2016.1237501

mtmt:3132521
Online Access:http://publicatio.bibl.u-szeged.hu/9938

Hasonló tételek